TCTR20220106001招募中3 期
Clinical outcomes of pharmacokinetic and pharmacodynamic meropenem dosing in critically ill patients with sepsis or septic shock
Silpakorn university0 个研究点目标入组 92 人开始时间: 2022年1月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. 18 years and older
- •2. The patient is diagnosed with sepsis or septic shock who receive meropenem during 72 hours after diagnosis sepsis and 24 hours after diagnosis septic shock.
- •3. Patients have characteristics at least two of the following.
- •3.1 Patient is diagnosed with sepsis or SOFA and qSOFA scores greater than or equal 2 points.
- •3.2 Patient is diagnosed with sepsis shock or received vasopressors or mean arterial pressure less than 65 mm Hg and lactate greater than 2 mmol/L.
- •3.3 Patient admits to the intensive care unit.
- •4. Patient founds at least 1 in 4 sources of infection.
- •4.2 Abdominal
- •4.3 urinary tract
- •5. Patient signs inform consent to participate in prospective study.
排除标准
- •1. Patient is received meropenem for less than 3 days.
- •2. Patient have a history of receiving meropenem within 1 week prior to recruitment.
研究者
相似试验
终止
不适用
Beta-lactam pharmacokinetics in haematology patients with sepsis.Febrile neutropeniaHaematological malignancySepsisACTRN12618000110280Cancer Care Services, RBWH100
进行中（未招募）
不适用
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
尚未招募
不适用
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
招募中
不适用
Examining the pharmacokinetic and pharmacodynamic profile of biperidememory impairmentNL-OMON47428niversiteit Maastricht42
进行中（未招募）
1 期
Metabolism and effects of naloxone given as a spray in healthy volunteers and children.Sedation after opioid administrationPharmacokinetic profile after naloxone administered intranasallyEUCTR2013-005201-31-SEKarolinska University Hospital20